Related Experiment Video
Updated: Mar 25, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
Progress in the Rational Design for Polypharmacology Drug
Jinming Zhou1, Quanjie Li, Meng Wu
1Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China. zhou_jim@hotmail.com.
Current Pharmaceutical Design
|February 25, 2016
Summary
Developing polypharmacology drugs, which target multiple biological molecules, is crucial for modern drug discovery. Rational design strategies, including ligand-based, target-based, and hybrid approaches, are advancing this field despite inherent challenges.
Area of Science:
- Drug discovery and development
- Computational chemistry and biology
- Pharmacology
Background:
- Polypharmacology is a significant strategy in drug discovery, offering novel approaches to drug design.
- Developing polypharmacology drugs with specific profiles presents considerable challenges.
Purpose of the Study:
- To provide an overview of the importance of polypharmacology in drug design.
- To discuss current trends in the rational design of polypharmacology drugs.
Main Methods:
- Review and classification of existing methodologies for rational polypharmacology drug design.
- Focus on computational biology and chemistry advancements driving rational drug design.
Main Results:
- Methodologies are categorized into ligand-based design, target-based design, and hybrid approaches.
- These rational design strategies are key to discovering polypharmacology drugs.
Conclusions:
- The rational design of polypharmacology drugs is increasingly important due to computational advancements.
- Understanding these trends can aid in the future design and development of effective polypharmacology drugs.
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
418
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
418
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
73
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
73
01:28Dosage Regimens: Designs and Approaches
456
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
456
01:24Principles of Drug Action
9.4K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.4K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
64
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
64